VERGE GENOMICS
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
VERGE GENOMICS
Industry:
Biotechnology Genetics Health Care Machine Learning Neuroscience
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vergegenomics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
134.12 M USD
Technology used in webpage:
Viewport Meta Euro Google Font API Google Tag Manager Google Analytics Content Delivery Network Global Site Tag Google Analytics 4 COVID-19 UNPKG
Similar Organizations
Clear Gene
Clear Gene improving diagnostics, from cancer to Covid.
Engine Biosciences
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Protein Mechanics
It is developing cross-disciplinary computational techniques to accelerate drug-discovery and design.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eli Lilly
Eli Lilly investment in Series B - Verge Genomics
Lifeforce Capital
Lifeforce Capital investment in Series B - Verge Genomics
Tao Capital Partners
Tao Capital Partners investment in Series B - Verge Genomics
Vulcan Capital
Vulcan Capital investment in Series B - Verge Genomics
Threshold
Threshold investment in Series B - Verge Genomics
ALS Investment Fund
ALS Investment Fund investment in Series B - Verge Genomics
BlackRock
BlackRock investment in Series B - Verge Genomics
Alumni Ventures
Alumni Ventures investment in Series B - Verge Genomics
Section 32
Section 32 investment in Series B - Verge Genomics
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series B - Verge Genomics
Newest Events participated
Participated in Y Combinator Summer 2015 Demo Day
on 2015-08-18 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-06 | Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer |
| 2022-10-17 | Verge Genomics Appoints John Applegate as Chief Financial Officer |
| 2021-05-05 | Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer |
Official Site Inspections
http://www.vergegenomics.com Semrush global rank: 3.08 M Semrush visits lastest month: 5.01 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Verge Genomics"
Verge Genomics
Verge Genomics has pioneered the industry's most advanced all-in-human AI powered drug discovery platform. Our mission is to develop better drugs, faster using technology.See details»
Leadership — Verge Genomics
We believe that delivering on the promise of technology requires breaking down the silos between scientists and technologists. Unlike traditional biotechnology companies, our rapidly growing …See details»
Careers - Verge Genomics
Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. Verge is a team of founders: Excited to learn, roll up our sleeves, and make a real impact on the future of human health.See details»
Verge Genomics - Crunchbase Company Profile
Verge Genomics uses machine learning and human genomics to accelerate drug discovery. View contacts for Verge Genomics to access new leads and connect with decision-makers. Verge Genomics transforms drug discovery with …See details»
Verge Genomics - LinkedIn
Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics...See details»
Verge Genomics — Technology Pioneers 2020 - World …
We started Verge with the vision of building a therapeutics company that takes a patient-data driven approach to unlock a spectrum of therapies that have escaped traditional drug discovery, beginning with diseases where patients need …See details»
How Verge Genomics Uses AI To Tackle Parkinson’s, …
Apr 28, 2021 · Verge Genomics is taking a novel approach to speed drug discovery for devastating neurodegenerative diseases such as Parkinson’s, Alzheimer's and ALS. Rather than spending exhaustive time with...See details»
Verge Genomics - VentureRadar
Website: http://www.vergegenomics.com. Develops AI-enabled drug discovery solutions, transitioning to a comprehensive neuroscience biotech for innovative pharmaceutical …See details»
Verge Genomics | Company Overview & News - Forbes
Pharmaceutical startup Verge Genomics combines AI with human genome data to discover new drugs for neurodegenerative diseases like Alzheimer’s and Parkinson’s.See details»
Approach - Verge Genomics
Our end-to-end CONVERGE ® discovery platform is a closed-loop machine learning system combining industry-leading proprietary human genomics with advanced computational tools to predict new drugs with a higher probability of …See details»
Verge Genomics Company Profile 2024: Valuation, …
Developer of a drug discovery platform designed to accelerate the development of life-saving treatments for neurodegenerative diseases.See details»
Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized …
Nov 14, 2022 · SAN FRANCISCO-- ( BUSINESS WIRE )--Verge Genomics, a clinical-stage, tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human …See details»
Verge Genomics Company Overview, Contact Details
Verge Genomics, a clinical-stage biotechnology company specializing in AI-driven drug discovery using patient tissue data, has announced a multi-target collaboration with Alexion, …See details»
Verge Genomics - Craft
Verge Genomics is a biopharmaceutical company using systems biology to accelerate the development of treatments for neurodegenerative diseases. It offers a platform that uses …See details»
Verge Genomics Awarded as Technology Pioneer by World …
Jun 18, 2020 · Verge Genomics, the South San Francisco-based company that develops therapies for neurological diseases using machine learning, was selected among hundreds of …See details»
Verge Genomics CEO and Key Executive Team | Craft.co
Verge Genomics's key executives include Alice Zhang and 19 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via …See details»
Verge Genomics Announces Three-Year Collaboration With Lilly to ...
Jul 8, 2021 · Verge is focused on developing therapeutics for serious genetic diseases using human genomics and machine learning. Verge has created a proprietary all-in-human …See details»
Verge Genomics Announces Milestones in Collaboration with Lilly …
Nov 20, 2024 · Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge …See details»
Working at Verge Genomics - Glassdoor
At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based ... Mission: Accelerate development of life-saving …See details»
News - Verge Genomics
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS. Nov 20, 2024. Press Release. Read More →.See details»